Newbridge Financial Services Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97K | Hold |
13
| – | – | ﹤0.01% | 968 |
|
|
2025
Q1 | $5.46K | Sell |
13
-25
| -66% | -$10.5K | ﹤0.01% | 786 |
|
|
2024
Q4 | $15.7K | Buy |
38
+13
| +52% | +$5.38K | ﹤0.01% | 653 |
|
|
2024
Q3 | $12.6K | Hold |
25
| – | – | ﹤0.01% | 411 |
|
|
2024
Q2 | $12.2K | Sell |
25
-10
| -29% | -$4.87K | ﹤0.01% | 671 |
|
|
2024
Q1 | $18.9K | Hold |
35
| – | – | 0.01% | 615 |
|
|
2023
Q4 | $19.4K | Hold |
35
| – | – | 0.01% | 599 |
|
|
2023
Q3 | $15.3K | Hold |
35
| – | – | 0.01% | 709 |
|
|
2023
Q2 | $17.6K | Hold |
35
| – | – | 0.01% | 729 |
|
|
2023
Q1 | $17.5K | Buy |
35
+10
| +40% | +$5K | 0.01% | 772 |
|
|
2022
Q4 | $10.2K | Hold |
25
| – | – | 0.01% | 913 |
|
|
2022
Q3 | $8K | Buy |
+25
| New | +$8K | ﹤0.01% | 938 |
|